KOSMODE HEALTH SINGAPORE PTE LTD, CLINCHES “THE MOST TRANSFORMATIONAL COLLABORATION” 2023 SICC AWARDS IN PARTNERSHIP WITH NESTLÉ SINGAPORE AND NESTLÉ R&D CENTRE.
Achieving functional food security that is good for health of the people and health of the earth SINGAPORE, Dec. 12, 2023 /PRNewswire/ -- KosmodeHealth Singapore, proudly announces its triumphant win of "The Most Transformational Collaboration" at the prestigious 2023 SICC Awards, in collaboration with Nestlé Singapore Pte Ltd and Nestlé R&D Center Pte Ltd. This esteemed award recognizes the groundbreaking...
Fapon Shines at JITMM 2023
DONGGUAN, China, Dec. 20, 2023 /PRNewswire/ -- Fapon, a global leading life sciences company, showcased its expertise at the Joint International Tropical Medicine Meeting (JITMM) 2023, the leading tropical-medicine conference in Southeast Asia held in Bangkok, Thailand, from December 12th to 15th. Committed to fostering local collaboration and empowering local IVD industry in...
Positive Outcome from a Phase Ib Study in Australia Treating Patients with Androgenic Alopecia
SHANGHAI, Jan. 15, 2024 /PRNewswire/ -- Hope Medicine Inc. ('HopeMed'), a clinical-stage innovative biopharmaceutical company, announced recently that the company has completed a Phase Ib study, "An Open-Label Study, to Evaluate Safety, Tolerability, and Efficacy in Male and Female with Androgenetic Alopecia Treated with HMI-115 over a 24-Week Treatment Period". This study is led by Professor Rodney Sinclair...
IGIN: the first innovative device for automatic glove fitting, is now launching a pre-sale
DUBAI, UAE, Jan. 31, 2024 /PRNewswire/ -- Approximately 99,000 Americans die each year in hospitals due to infections acquired there, according to the Centres for Disease Control and Prevention (CDC). 3.5 million Europeans a year contract an infection while in hospital. IGIN Global, a pioneer in healthcare technology, is excited to announce the presale of its...
Lumosa Therapeutics and CHI Memorial announce new study for acute stroke
TAIPEI and CHATTANOOGA, Tenn., Feb. 2, 2024 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; 6535.TWO), together with CHI Memorial have announced the initiation of a Phase 2b clinical trial for LT3001, a groundbreaking drug for treating acute stroke. This new drug combines clot-busting and nerve-protecting effects into one treatment, potentially revolutionizing acute stroke therapy. Stroke, a leading cause of adult disability globally,...
Ajinomoto Bio-Pharma Services Garners Six ‘CDMO Leadership Awards,’ Further Establishing Its Industry Excellence
SAN DIEGO and TOKYO and WETTEREN, Belgium, March 12, 2024 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, received CDMO Leadership Awards in all six categories - Capabilities, Compatibility, Expertise, Quality, Reliability, and Service for both the Overall and Big Pharma respondent groups. Of...
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Greater sense of patient empowerment with telemedicine trends in IVF services
SINGAPORE, April 29, 2022 /PRNewswire/ -- Telemedicine that became a vital engagement tool between health professionals and patients during the COVID-19 pandemic is emerging as a welcome new treatment of choice among fertility clinics and couples striving for parenthood. Patients seeking assisted conception services, such as IVF, are increasingly interacting by telephone and...
Zhongchao Inc. Reports the Fiscal Year 2021 Financial Results
SHANGHAI, May 9, 2022 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patient management service, today announced its financial results for the fiscal year ended December 31, 2021. Key Financial Highlights for the Fiscal Year 2021 as compared to...
A Painless, Micro Injection that One Can Do Oneself with the Latest Chula’s Innovation “Detachable and Dissolvable Microneedles”
BANGKOK, June 23, 2022 /PRNewswire/ -- A startup under the umbrella of CU Innovation Hub in collaboration with the Chula Faculty of Science has developed an innovative "Detachable and Dissolvable Microneedle" that makes any injections easy and painless for everyone, while also significantly reducing medical wastes. Those afraid of needles and injections...
Seegene develops PCR test to detect monkeypox virus
Assay targets monkeypox virus and can deliver results in 90 minutes Company swiftly rolls out product using its automated assay development system "Seegene will strive to make accurate tests for emerging viruses to help prevent future pandemics" SEOUL, South Korea, June 28, 2022 /PRNewswire/ -- Seegene Inc. (KQ965390), South...
